This should include a comprehensive analysis of pharmaceutical agents used to regulate ventricular rate in atrial fibrillation, such as beta blockers, calcium channel blockers, digoxin, amiodarone, and ACE inhibitors, as these have been shown to reduce the risk of post-stroke aspiration pneumonia. This evidence concerns the gene ACE and Stroke.